LSE - Delayed Quote GBp
Hemogenyx Pharmaceuticals Plc (HEMO.L)
180.00
-5.25
(-2.83%)
As of 12:39:13 PM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-6,105.57
-6,105.57
-2,910.60
-2,627.30
-1,798.40
Investing Cash Flow
-31.94
-31.94
-420.25
-938.95
-169.68
Financing Cash Flow
4,449.31
4,449.31
-110.14
8,777.64
3,212.02
End Cash Position
1,247.60
1,247.60
2,532.76
6,840.97
1,812.30
Capital Expenditure
-117.29
-117.29
-428.95
-818
-173.05
Issuance of Capital Stock
5,088.08
5,088.08
--
--
35.07
Issuance of Debt
--
--
--
12,000
3,609.98
Repayment of Debt
--
--
--
-3,183.28
--
Free Cash Flow
-6,222.86
-6,222.86
-3,339.55
-3,445.30
-1,971.45
12/31/2020 - 11/9/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
8AW0.MU Ocean Biomedical Inc
0.0220
0.00%
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0070
+100.00%
PBMWW Psyence Biomedical Ltd.
0.0148
+42.31%
ACUT AccuStem Sciences, Inc.
0.4200
+7.69%
SAR.L Sareum Holdings plc
16.45
+2.81%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%
AVCT.L Avacta Group Plc
31.00
-6.06%
688238.SS Obio Technology (Shanghai) Corp., Ltd.
5.79
-0.69%
PXMD PaxMedica, Inc.
0.0001
0.00%
HVO.L hVIVO plc
16.68
+1.83%